Lumakras

Amgen hold-up gives Mirati a vital lifeline
EP Vantage
Thu, 02/10/22 - 10:12 am
Amgen
Mirati Therapeutics
Lumakras
lung cancer
clinical trials
Why did FDA ask Amgen to add low-dose trial of Lumakras?
Korea Biomed
Wed, 11/3/21 - 10:47 am
FDA
Amgen
clinical trials
Lumakras
oncology
cancer
Amgen to advance KRAS drug combination after improved results in colon cancer
BioPharma
Thu, 09/16/21 - 10:40 pm
Amgen
Lumakras
clinical trials
colon cancer
Amgen's high-profile cancer med Lumakras set for rollout in England thanks to NHS access deal
Fierce Pharma
Sat, 09/11/21 - 10:18 pm
Amgen
Lumakras
UK
NHS
cancer
Mirati fiddles as its share price burns
EP Vantage
Thu, 08/12/21 - 11:07 am
Mirati Therapeutics
Amgen
Lumakras
adagrasib
Frontier Medicines raises $88M for R&D, including potential rival to Amgen cancer drug
MedCity News
Wed, 07/21/21 - 12:06 am
Frontier Medicines
Amgen
cancer
Lumakras
Amgen lands first FDA approval for drug targeting elusive mutation in lung cancer
MedCity News
Sat, 05/29/21 - 04:52 pm
Amgen
FDA
sotorasib
Lumakras
KRAS mutation
Amgen’s low-dose Kras curveball
EP Vantage
Thu, 04/29/21 - 10:40 am
Amgen
FDA
Lumakras
sotorasib

Pages